Novartis kicked off a new era in US medicine on Thursday with the launch of the first “biosimilar” copy of a biotechnology drug approved in the United(...)

A screen shows the final tally for the Dow Jones Industrial Average on the floor of the New York Stock Exchange, yesterday.  Photograph: Brendan McDermid/Reuters

World stock markets tumbled towards their worst week of the year yesterday and commodities got another kicking, as more alarming data from China sent(...)

New cancer drug cocktails set to reach the market in the next few years will test the limits of premium pricing for life-saving medicines, forcing com(...)

Kingspan chief executive Gene Murtagh: The company came under some pressure, and was one of the big fallers onISEQ index. Photograph: Irish Times

European stocks declined, snapping a nine-day winning streak, amid mixed earnings reports. Stocks on Wall Street fell, with results from bellwethers I(...)

The Novartis AG headquarters stand in Basel, Switzerland.  The company said its earnings were hit in the second quarter by a stronger US dollar. Photograph: Peter Frommenwiler/Bloomberg

Pharmaceutical firm Novartis saw its second quarter earnings fall by 7 per cent as the strength of the US dollar hit sales. The company said it(...)

The Quartz was completed by Bernard McNamara before going into bankruptcy with debts of €2.7bn

A long-vacant office building at Elm Park on the Merrion Road in Dublin 4 has finally been let to two international companies, a global insurance b(...)

Packets of medicines sit in a drawer inside a pharmacy store  in Athens, Greece. Photographer: Kostas Tsironis/Bloomberg

Drugmakers said on Monday they would continue to ship medicines to Greece in coming weeks, despite mounting unpaid bills, but warned supplies could be(...)

Perrigo chief executive and chairman Joe Papa.  Photograph: Brenda Fitzsimons / The Irish Times

Perrigo, the Irish specialist in over the counter drugs, has agreed to buy a portfolio of products from GlaxoSmithKline. GSK’s consumer healthcare div(...)

Novartis is making the leap into medtech with a collaboration with Rani Therapeutics on a “robotic” pill. Photographer: Gianluca Colla/Bloomberg

Swiss drugmaker Novartis is raising its bet on smart technology by collaborating with US start-up Rani Therapeutics on a “robotic pill” for complex bi(...)

A new €5 million research centre which will see industry and academia collaborate on specific health projects was officially launched today.The Applie(...)